https://doi.org/10.1016/j.jare.2021.07.011
Y
Yingying Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
137
Papers
1.9K
Citations
23
h-index
46
i10-index
Yingying Zhang is an academic researcher from Nanjing Tech University. The author has contributed to research in topics: Autophagy in Disease and Therapy & Respiratory viral infections research & Flavonoids in Medical Research. The author has an h-index of 23, co-authored 117 publications.
ORCID: 0009-0008-0207-1490Papers by this author
worksGut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients
2021 · Journal of Advanced Research · 73 citations
Human adenovirus (HAdV) infection in children with acute respiratory tract infections in Guangzhou, China, 2010–2021: a molecular epidemiology study
2022 · World Journal of Pediatrics · 63 citations
https://doi.org/10.1007/s12519-022-00590-w
Systemic Revealing Pharmacological Signalling Pathway Networks in the Hippocampus of Ischaemia-Reperfusion Mice Treated with Baicalin
2013 · Evidence-based Complementary and Alternative Medicine · 11 citations
https://doi.org/10.1155/2013/630723
Utilizing Engineered Bacteria as “Cell Factories” <i>In Vivo</i> for Intracellular RNA-Loaded Outer Membrane Vesicles’ Self-Assembly in Tumor Treatment
2024 · ACS Nano · 11 citations
https://doi.org/10.1021/acsnano.4c11412
Applications of artificial intelligence-powered prenatal diagnosis for congenital heart disease
2024 · Frontiers in Cardiovascular Medicine · 10 citations
https://doi.org/10.3389/fcvm.2024.1345761
Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
2021 · Trials · 8 citations
https://doi.org/10.1186/s13063-021-05028-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat